Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide delivery.
Saved in:
| Title: | Gut microbiota perturbation and systemic inflammation are associated with salcaprozate sodium (SNAC)-enabled oral semaglutide delivery. |
|---|---|
| Authors: | Ariaee A; Translational Nanomedicines and Biotherapeutics, University of South Australia, Adelaide, SA 5000, Australia; Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia., Noueihad K; Translational Nanomedicines and Biotherapeutics, University of South Australia, Adelaide, SA 5000, Australia; Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia., Hunter A; Translational Nanomedicines and Biotherapeutics, University of South Australia, Adelaide, SA 5000, Australia; Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia., Wignall A; Translational Nanomedicines and Biotherapeutics, University of South Australia, Adelaide, SA 5000, Australia; Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia., Wardill HR; Adelaide Medical School, The University of Adelaide, Adelaide, SA 5000, Australia; Supportive Oncology Research Group, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia., Davies M; Adelaide Medical School, The University of Adelaide, Adelaide, SA 5000, Australia; Supportive Oncology Research Group, South Australian Health and Medical Research Institute, Adelaide, SA 5000, Australia., Prestidge CA; Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia., Joyce P; Translational Nanomedicines and Biotherapeutics, University of South Australia, Adelaide, SA 5000, Australia; Centre for Pharmaceutical Innovation, University of South Australia, Adelaide, SA 5000, Australia. Electronic address: paul.joyce@unisa.edu.au. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 Apr 10; Vol. 392, pp. 114711. Date of Electronic Publication: 2026 Feb 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
